0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

´ëÇÑÁ¾¾ç°£È£ÇÐȸ °æ±¸Ç×¾ÏÁ¦ ½Ç¹«Áöħ

Korean Oncology Nursing Society Guidelines on Oral Chemotherapy

Á¾¾ç°£È£¿¬±¸ 2017³â 17±Ç 4È£ p.201 ~ 212
KMID : 1035120170170040201
¹ÚÁ¤À± ( Park Jeong-Yun ) - ¿ï»ê´ëÇб³ ÀÓ»óÀü¹®°£È£ÇÐ

°û¹Ì°æ ( Kwak Mi-Kyong ) - »ï¼º¼­¿ïº´¿ø
¹ÚÈñÁ¤ ( Park Hee-Jung ) - ±¹¸³¾Ï¼¾ÅÍ
¼Û¼ö°æ ( Song Su-Kyung ) - ¼¼ºê¶õ½ºº´¿ø
À±ÁöÇö ( Yun Ji-Hyun ) - ¼­¿ï¾Æ»êº´¿ø
Á¶ÇöÁø ( Cho Hyun-Jin ) - ¼­¿ï¼º¸ðº´¿ø
Á¤ÁöÀ± ( Jung Ji-Yoon ) - ¼­¿ï¾Æ»êº´¿ø

Abstract

Purpose: In 2008, the Korean Oncology Nursing Society (KONS) published standards for the safe use of chemotherapy in clinical settings, including extravastion management. Although the medical environment has rapidly changed, KONS standards have not been revised since then. In 2017, the KONS planned to revise the practice guidelines on oral chemotherapy.

Methods: A clinical expert group developed recommended guidelines, using officially accepted standards based on all relevant publications. The draft was discussed and accepted in a consensus conference. The final recommendations were reviewed and approved by the KONS Boards of Directors.

Results: There were 4 chapters and 50 recommendations in the final version of the guidelines. Recommendations include those associated with general practice, patient consent and education, order assessment and administration, and side effects and complication management.

Conclusion: The revised KONS guidelines on oral chemotherapy will contribute to the improvement of staff and patient safety related to oral chemotherapy. KONS guidelines revisions should be carried out at regular intervals.
KeyWords
Ç×¾ÏÁ¦, °æ±¸Ç×¾ÏÁ¦, ¾ÈÀü°ü¸®, °³Àκ¸È£À屸, °¡À̵å¶óÀÎ
Drug Therapy, Oral Chemotherapy, Safety Management, Personal Protective Equipment, Guideline
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed